1800 202 8726
Liver biopsy and bleeding risk

Liver Biopsy With Cirrhosis — or Clotting Problems

If you have cirrhosis or clotting problems and need a liver biopsy, the standard approach carries a higher bleeding risk. A different route — through a vein in your neck rather than the abdominal wall — was designed for exactly this situation, and is the one your team should discuss with you first.

Medically reviewed by Dr. Muralidhar Muddusetty, Surgical Oncologist, MBBS (AIIMS) · MS Surgery (AIIMS) · DNB Surg Onc · MRCS (Edinburgh) · Last reviewed September 2026

  • The route can be changed — The standard percutaneous approach is not the only option when clotting is impaired.
  • Blood tests come first — Clotting and platelet count are checked before any biopsy decision is made.
  • The transjugular route keeps bleeding inside your circulation — Tissue is taken from inside a liver vein, not through the abdominal wall.
  • Overnight observation is usual — Most patients having a transjugular biopsy are monitored overnight as a precaution.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

A liver biopsy is still possible when you have cirrhosis or clotting problems — but the route matters. The transjugular approach accesses the liver through a vein in your neck rather than through the abdomen, and is designed for patients whose clotting cannot safely be corrected. Your team will assess your clotting first and decide which route is right for you.

Is a liver biopsy safe when your clotting is not normal?

The standard liver biopsy passes a needle through the abdominal wall. When clotting is impaired — as it commonly is in cirrhosis — the bleeding risk from that route is higher.

Your team will check your clotting before any biopsy is arranged. If it falls outside the safe range, there are two options: correct it temporarily with blood products, or use the transjugular route, which does not depend on normal clotting.

Guidance from AASLD and EASL recommends the transjugular approach when significant coagulopathy cannot be adequately corrected, or when ascites makes the abdominal route unsafe.

What is a transjugular liver biopsy?

In a transjugular biopsy, the doctor guides a thin tube through the jugular vein in your neck, through the right side of the heart, and into the hepatic vein — the large vein that drains the liver.

The biopsy needle then enters liver tissue through the vein wall. Because it never crosses the outer liver capsule or the abdominal skin, any bleeding stays inside your own circulation.

This is what makes it suitable when clotting is poor. The main complication of standard biopsy — free bleeding into the abdomen — is largely avoided.

What happens before and during a transjugular liver biopsy?

  1. Blood tests

    Clotting values, platelet count, and blood group are checked before any procedure date is set.

  2. Route decision

    A specialist reviews the results and chooses between correcting clotting first, using the transjugular route, or deferring the biopsy.

  3. Day preparation

    You fast for several hours beforehand. A drip is placed in your arm. The neck is cleaned and numbed with local anaesthetic.

  4. The procedure

    A thin tube is guided to the hepatic vein under X-ray. Tissue samples are taken through the vein wall. The procedure usually takes less than an hour.

  5. Observation

    You are monitored for several hours afterwards. An overnight stay is usual. Nurses check pulse, blood pressure, and the neck entry site.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What if clotting cannot be corrected enough?

For some patients with advanced cirrhosis, clotting values remain significantly abnormal even after blood products. The transjugular route is still the recommended approach — its bleeding risk is lower than the percutaneous route, not absent.

There are also situations where biopsy would not change the treatment plan. Your team should explain this before asking you to agree to proceed.

If transjugular biopsy is unavailable at your centre, ask whether a referral to a specialist centre is needed.

Terms your team may use

INR
A measure of how long your blood takes to clot. A higher number means slower clotting and greater bleeding risk during a procedure.
Coagulopathy
Impaired clotting. Cirrhosis causes it because the liver produces most of the proteins blood needs to clot normally.
Percutaneous biopsy
The standard route — a needle through the abdominal skin into the liver, guided by ultrasound.
Transjugular biopsy
A biopsy taken through the jugular vein in the neck, entering the liver from inside the hepatic vein rather than through the abdominal wall.
Ascites
Fluid in the abdominal cavity, common in advanced cirrhosis. It adds to the case for avoiding the standard abdominal biopsy route.
Fresh frozen plasma (FFP)
A blood product containing clotting proteins, sometimes given before biopsy to temporarily improve clotting when values are borderline.

Questions families often ask

Can we refuse the biopsy if we are worried about bleeding?

Yes. You can always ask for more information before agreeing to a procedure. What helps is knowing what question the biopsy answers and whether treatment decisions rest on that result. If the result would not change the plan, ask whether biopsy can wait. If it would, your team can explain the specific bleeding risk for the route they are proposing and what happens if you choose not to proceed. Refusal is your right, and the consequences should be explained without pressure.

Will my relative need blood products before the procedure?

Possibly. If clotting values or platelet count fall outside the range considered safe, the team may give fresh frozen plasma or platelets beforehand to reduce the risk temporarily. This corrects clotting for the procedure — it does not treat the cirrhosis itself. Your team will tell you whether this applies in your relative's case before proceeding. Not everyone with cirrhosis needs pre-procedure blood products; it depends on how abnormal the values are and which route is planned.

Is transjugular liver biopsy available across India?

Transjugular biopsy requires an interventional radiology team and X-ray guidance equipment, so it is not available at every hospital. It is generally performed at larger tertiary and teaching hospitals. If your treating centre does not offer it, ask whether a referral is needed — the centre for the biopsy may not be the same as the one managing your ongoing care. CION coordinates with specialist centres when the transjugular approach is clinically indicated.

Is it done under general anaesthesia?

No, not routinely. Transjugular liver biopsy is usually done under local anaesthesia with sedation — you are relaxed and drowsy but not unconscious. The neck entry site is numbed so the catheter insertion is not painful. You may feel mild pressure during the procedure. If anything feels sharp, tell the team immediately. They will explain each step before starting.

How long before we get the biopsy result?

The tissue goes to a pathology laboratory for processing and analysis. Results typically take from a few days to about two weeks, depending on the laboratory and whether additional staining is needed on the sample. Your team will tell you when to expect the report and whether they will call you or ask you to come in. A longer wait does not mean a worse result — complex samples take longer to process.

What signs at home mean we should seek help immediately?

Seek emergency care if your relative develops severe abdominal or right-shoulder pain, worsening breathlessness, a fast or pounding heart rate, or bleeding from the neck entry site that does not stop with firm pressure. Fever in the first 48 hours should be reported to your team the same day rather than waited out. Mild soreness at the neck site and slight right-sided discomfort are expected and usually settle. When in doubt, call rather than wait.

Explore 133 more Biopsy by Body Part topics

HUB — Biopsy by Body Part

All Biopsy by Body Part →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Why does cirrhosis affect clotting?

The liver produces most of the proteins that allow blood to clot normally. When cirrhosis damages liver cells over time, production of those proteins falls. This is why clotting values such as INR are often abnormal in cirrhosis, even without any visible bleeding episode. The degree of clotting impairment is also one of the markers your team uses to gauge how advanced the cirrhosis is, which directly informs the biopsy decision.

What blood tests come before a liver biopsy?

Your team will check clotting — usually INR or prothrombin time — and platelet count, because both affect bleeding risk. Blood group and cross-match are done in case a transfusion is needed. Kidney function is often checked too. These results, together with imaging and your overall condition, determine which biopsy route is appropriate and whether any correction is needed first.

How is a transjugular biopsy different from a standard one?

A standard biopsy passes a needle through the abdominal skin into the liver, guided by ultrasound. The transjugular approach enters through a neck vein and reaches the liver from inside the hepatic vein, never crossing the outer liver wall or the abdominal skin. Bleeding from the biopsy site drains back into your circulation rather than into the abdominal cavity — which is what makes it significantly safer when clotting is impaired.

Will a transjugular biopsy give enough tissue for a reliable result?

Transjugular biopsy sometimes yields smaller fragments than a percutaneous biopsy. Experienced interventional radiologists usually obtain enough for a reliable diagnosis, and multiple passes can be made through the same neck entry point without an additional skin puncture. Your team will say if there is any concern about sample size after the procedure and whether anything further is needed.

How long will my relative need to stay in hospital?

Overnight observation is standard after transjugular liver biopsy, particularly when clotting is impaired. Your relative will be monitored for signs of bleeding — pulse, blood pressure, and the neck entry site — throughout. If observations are normal the following morning, discharge is usually possible. Your team will advise on activity restrictions and what to watch for at home. Bring someone to accompany your relative on the day.

When might the team advise against biopsy altogether?

Biopsy may be deferred when the risk outweighs what it would add. This can happen when imaging already gives a confident enough diagnosis, when treatment would be the same regardless of the result, or when overall condition makes even the transjugular route too risky. Ask your oncologist or hepatologist directly: what does the biopsy answer, and what changes if we do not proceed? Those are reasonable questions that deserve a clear answer.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation